Glaxo Sells Stake in South Africa’s Aspen for $619 Million

Updated on
  • Aspen shares have risen 6-fold over the seven-year investment
  • Glaxo sold two further tranches of Aspen shares in 2013, 2015

GlaxoSmithKline Plc ended its seven-year run as an investor in Aspen Pharmacare Holdings Ltd., selling the final portion of its stake in the South African company for about $619 million.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.